Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Evolv Technologies Holdings, Inc. EVLV

Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.

Insider Decisions

Total buys
0.70
Total sells
9.77
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy 3 2 1
Sell 2 1 1 2 1 1 1 2 2 1 1
Insider Ownership
6.32%

Capital & Financial Ratios

Market Cap
925.56
Revenue
171.44
Net Income
(5.22)
Free Cash Flow
(5.54)
Net Debt
(34.63)
Current Ratio
1.18
Debt/Equity
0.24
P/E ratio
0.00
P/S ratio
5.26
P/B ratio
7.59
Past 5Y EPS Growth
42.09%
This Y EPS Growth
(2.50%)
Next Y EPS Growth
29.27%
Next 5Y EPS Growth
24.24%
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
Annual Dividend Yield
total individual payouts
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 118.73 51.94 69.04 63.37
Receivables 21.55 28.39 30.84 39.58
Inventory 10.34 16.96 9.32 8.66
Other 5.78 6.23 6.94 8.12
173.36 121.45 151.30 149.41
2023 2024 2025 Q'26
Payables 17.40 10.49 9.77 12.25
ST’ Debt
Other
81.30 96.71 122.98 126.85
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡ ‡‡‡
Earnings ‡‡‡ ‡‡‡
Book Value ‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 46.33 43.75
’25 32.01 32.54 42.85 38.50
145.91
’24 22.18 25.22 27.36 29.10
103.87
’23 18.58 19.83 19.96 21.20
79.57
’22 8.71 9.07 16.53 18.41
52.72
’21 4.00 4.68 8.42 6.29
23.39
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (3.18) 11.90
’25 (2.54) 2.11 3.52 15.57
18.67
’24 (16.15) (21.58) 3.68 3.20
(30.85)
’23 (3.43) (5.32) 2.10 (3.14)
(9.80)
’22 (29.43) (23.06) (16.93) (5.32)
(74.74)
’21 (12.04) (6.25) (24.27) (14.22)
(56.78)
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (8.14) 2.09
’25 (16.82) (2.01) (11.48) 12.00
(18.32)
’24 (37.54) (24.92) (0.81) (4.89)
(68.17)
’23 (17.47) (25.99) (16.98) (21.75)
(82.20)
’22 (36.85) (28.33) (23.42) (10.01)
(98.61)
’21 (14.56) (11.69) (27.31) (20.81)
(74.37)
in millions of $

EPS

Mar Jun Sep Dec Year
’26 (0.03) (0.05)
’25 (0.01) (0.25) (0.01) 0.06
(0.20)
’24 (0.08) 0.02 (0.19) (0.10)
(0.34)
’23 (0.20) (0.45) 0.03 (0.11)
(0.71)
’22 (0.10) (0.18) (0.13) (0.19)
(0.60)
’21 (0.19) (0.71) 0.15 0.02
(0.15)

Target Price Range

High
‡‡‡‡‡
‡‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡

Recommendation Rating

1
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡ ‡‡‡‡ 1.57 2.29 2.01 2.64
Low Price
‡‡‡‡‡ ‡‡‡‡ 4.88 8.30 5.73 8.91
High Price
‡‡‡ ‡‡‡‡‡ 225 293 287 286
Employees
‡‡‡‡‡ ‡‡‡‡‡ 0.23 0.27 0.36 0.51
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ 52.72 79.57 103.87 145.91 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ 2.66% 40.10% 57.25% 51.61%
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ (86.79) (108.00) (54.02) (33.08)
EBT
‡‡‡‡‡ ‡‡‡‡‡ (164.64%) (135.73%) (52.01%) (22.67%) ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (86.79) (108.05) (54.02) (33.14) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ 5.44 9.70 17.38 24.34
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ 0.37 0.53 0.66 0.87 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡‡ ‡‡‡‡‡ (0.60) (0.71) (0.34) (0.20) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ (0.52) (0.07) (0.20) 0.11
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ (0.17) (0.49) (0.24) (0.22) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ (0.69) (0.55) (0.44) (0.11)
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ 1.58 0.97 0.75 0.71
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ 143.86 149.17 156.57 168.42 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡ ‡‡‡ 0.00 0.00 0.00 0.00 ‡‡‡‡‡ ‡‡‡‡‡
PE Ratio
‡‡‡ ‡‡‡‡‡ 6.74 8.96 5.95 8.26 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡ ‡‡‡‡‡ 1.57 4.95 5.26 10.10 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡ ‡‡‡‡‡ 2.94 7.49 5.47 8.00 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡ ‡‡‡‡‡ (1.57) (7.25) (8.34) (63.69)
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ (74.74) (9.80) (30.85) 18.67 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ (23.87) (72.40) (37.31) (36.99) ‡‡‡‡‡
Capex
‡‡‡‡‡ ‡‡‡‡‡ (98.61) (82.20) (68.17) (18.32) ‡‡‡‡‡
FCF
‡‡‡‡‡ ‡‡‡‡‡ 233.46 92.06 24.74 28.33
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ 29.68 28.60
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ (200.10) (118.73) (51.94) (40.44)
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ 226.99 144.14 117.65 119.42
Sh' Equity
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (24.42%) (33.49%) (19.11%) (11.58%)
ROA
‡‡‡‡‡ ‡‡‡ (239.33%) (221.47%) (78.29%) (38.35%)
ROIC
‡‡‡‡‡ ‡‡‡‡‡ (33.56%) (58.23%) (41.27%) (27.96%)
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Evolv Technologies (EVLV) has delivered eye-popping revenue growth since its 2021 SPAC debut, surging from $4.8 million in 2020 to $103.9 million in 2024, driven by AI-powered weapons detection systems amid heightened public safety demands at schools, events, and venues like NFL stadiums. Gross margins have rebounded impressively to 57%, with subscriptions now dominating revenue and operational efficiency improving via higher revenue per employee. Analysts project continued expansion to $194.9 million by 2027, fueling optimistic price targets implying 67-76% upside from depressed levels near recent lows.

Yet, this growth masks serious downside risks: persistent net losses narrowing but still at $54 million in 2024, free cash flow deeply negative at -$68.2 million, and relentless share dilution inflating the count over 17-fold to 156.6 million, eroding per-share value. Balance sheet pressures persist with negative ROIC at -78%, shrinking equity, and heavy capex bets on R&D that show no profitability payoff yet.

Insider selling—$18.7 million in outflows versus minimal buys—signals caution amid decelerating growth, execution hiccups, and looming competition, questioning if EVLV is a coiled spring or a value trap. With FCF inflection years away and high valuations pricing in perfection, prudent investors should scrutinize these pitfalls before chasing the hype. Read the full analysis for deeper balance sheet insights and risk assessment.

Evolv Technologies Holdings, Inc. (EVLV) Latest News

News by impact score

Fine-tune

23 Aug

3 , 10:10 PM
Evolv Technologies Holdings extended its contract with the Texans and raised guidance, challenging the undervalued stock narrative. Contract extension plus raised guidance signals moderate positive effects on operations and sentiment without major trajectory shifts.

18 Aug

4 transcript www.fool.com, 6:58 PM
Evolv (EVLV) released its Q2 2026 earnings call transcript covering financial results and operations. Q2 2026 earnings call details financial metrics and outlook with direct effect on EVLV valuation and strategy.

14 Aug

4 , 8:00 AM
Evolv Technology expands market reach and deepens customer adoption amid strong demand for AI-powered security. Market expansion combined with deeper customer adoption signals significant positive influence on future performance.

12 Aug

4 transcript , 1:02 AM
Evolv Technologies Holdings Inc (EVLV) highlighted record customer achievements in its Q2 2026 earnings call. Record customer results point to stronger demand and revenue potential that can shift company trajectory.

11 Aug

3 transcript app.moby.co, 8:41 PM
Evolv Technologies Holdings, Inc. discussed Q2 2026 financial results, revenue, and outlook during its earnings call. Standard earnings call provides updates on financials and guidance with moderate influence on near-term stock sentiment.

3 transcript www.marketbeat.com, 6:04 PM
Evolv Technologies Holdings reported Q2 financial results and discussed operational updates, revenue trends, and strategic priorities during its earnings call. Q2 earnings call supplies financial metrics and outlook that can moderately shift near-term sentiment and operational expectations.

3 , 4:05 PM
Evolv Technology reported its second quarter financial results. Quarterly results updates can moderately affect financial performance views and investor sentiment for Evolv Technologies.

7 Aug

3 , 10:17 AM
Evolv Technologies Holdings secures Ryan Field deal. Questions persist on whether EVLV stock is undervalued by 41%. Ryan Field contract adds revenue but leaves core operations and competitive position largely unchanged.

5 Aug

3 , 8:00 AM
New Ryan Field selects Evolv Express® as official fan screening provider to enhance security and establish the venue as the best place to watch football in America. Single venue deployment adds incremental adoption for Evolv Express in sports settings.

1 Jul

3 , 8:00 AM
Evolv Technologies renews multi-year contract at TD Garden in Boston and adds Evolv eXpedite bag scanners to extend its market presence. Multi-year renewal plus new scanner deployment at single major venue signals moderate operational growth without altering overall trajectory.

19 Jun

4 , 3:01 AM
Evolv Technology (EVLV) receives DHS SAFETY Act Designation for eXpedite Screening System. DHS SAFETY Act Designation for eXpedite Screening System boosts Evolv's regulatory credibility and government sales potential.

18 Jun

4 , 6:43 AM
Evolv Technologies (EVLV) received Safety Act Designation for its AI-driven bag screening solution. Safety Act Designation grants liability protections that strengthen product credibility and accelerate adoption in security markets.

10 Jun

3 Business Wire, 8:00 AM
Evolv eXpedite™ received SAFETY Act Designation as Qualified Anti-Terrorism Technology, joining Evolv Express®. Designation adds regulatory credibility that can aid sales in security markets without altering core operations.

8 Jun

3 Simply Wall St., 4:07 AM
Evolv Technologies renewed its security contract with the Philadelphia Phillies, highlighting venue screening technology and drawing renewed investor attention to the company's growth prospects. Contract renewal with a major sports franchise supports recurring revenue and raises company visibility among investors.

4 Jun

3 Business Wire, 8:00 AM
Evolv Technologies renews multi-year partnership with Philadelphia Phillies to expand deployment of Evolv Express security screening systems at stadium venues. Multi-year renewal secures additional recurring revenue from a major sports client but affects only a narrow segment of operations.

29 May

4 www.marketbeat.com, 1:02 PM
Evolv Technologies reports 45% Q1 growth, raises full-year outlook, and advances AI screening technology. Reported growth, raised outlook and AI push signal stronger financial results and competitive gains.

23 May

3 Simply Wall St., 8:13 AM
Evolv Technologies Holdings enters class action settlement, highlighting ongoing legal challenges and potential impacts on company valuation. Class action settlement introduces legal risks and questions over company valuation.

13 May

4 www.fool.com, 7:37 PM
Evolv Technologies Holdings (EVLV) stock plummeted over 20% today after the company announced weaker-than-expected Q3 results, lowered full-year guidance, and faced concerns over slowing demand for its AI weapon-detection systems. Disappointing earnings and guidance cut signal significant pressure on near-term financial performance and investor confidence.

4 GuruFocus.com, 1:01 AM
Evolv Technologies Holdings Inc (EVLV) reported strong revenue growth in Q1 2026 earnings call, alongside key operational highlights. Strong revenue growth in Q1 2026 signals significant positive shift in financial trajectory and investor sentiment.

3 transcript app.moby.co, 8:30 AM
EVLV held its Q1 2026 earnings call, presenting financial results, operational updates, and forward guidance for investors. Earnings call outcomes typically shift near-term valuation and sentiment without guaranteeing structural change.

12 May

4 www.marketbeat.com, 7:07 PM
Evolv Technologies Holdings, Inc. (EVLV) released highlights from its Q1 earnings call, covering financial results, operational updates, and forward-looking guidance. Q1 earnings highlights disclose financial performance and guidance that significantly shape investor sentiment and stock trajectory.

4 Business Wire, 4:05 PM
Evolv Technologies Holdings, Inc. (EVLV) reported first quarter financial results, including revenue of $32.0 million, up 53% year-over-year, record bookings, and raised full-year guidance. Strong Q1 revenue growth and raised guidance signal significant positive momentum for future performance and investor confidence.

3 Zacks, 5:40 PM
Evolv Technologies Holdings, Inc. (EVLV) reported a Q1 net loss but beat revenue estimates. Q1 revenue beat despite net loss moderately affects financial performance and market sentiment without fundamentally altering trajectory.

7 May

4 Business Wire, 8:05 AM
Evolv Technology screens over 4 million people daily and introduces the 'Screened by Evolv™' seal to recognize venues using its threat detection systems. Launching a branded seal while screening 4+ million daily underscores massive operational scale and boosts marketing appeal to partners and investors.

21 Apr

3 , 8:05 AM
University of Washington selects Evolv Express® to enhance security at its football stadium and basketball arena on the Seattle campus. University of Washington's deployment at high-traffic stadium and arena validates Evolv's technology in sports venues and supports revenue growth.

17 Apr

4 Insider Monkey, 10:53 AM
Evolv Technologies (EVLV) compounding growth stems from strong product demand, recurring revenue model, expanding addressable market in threat detection, and operational efficiencies driving margin expansion and scalability. Identification of core compounding drivers like recurring revenue and market expansion signals significant long-term growth potential and positive investor sentiment for EVLV.

9 Apr

4 Simply Wall St., 4:10 PM
Analysts express optimism for Evolv Technologies Holdings (EVLV) after Omnigo partnership announcement, prompting valuation analysis highlighting growth potential in security tech. Omnigo partnership expands EVLV's security ecosystem while analyst optimism boosts investor sentiment and valuation prospects.

6 Apr

4 Zacks, 9:55 AM
Wall Street analysts predict a 65.84% upside for Evolv Technologies Holdings, Inc. (EVLV) stock, highlighting strong buy ratings and target prices amid robust growth prospects in security screening technology. Analyst consensus of 65.84% upside targets major positive shift in investor sentiment and potential stock trajectory.

4 www.fool.com, 6:20 AM
Evolv Technologies Holdings, Inc. (EVLV) stock jumped 14.2% last month and continued surging in April due to strong demand for its AI-powered security screening technology, key contract wins, and expanding partnerships. Stock surge driven by robust product demand and new contracts significantly boosts investor sentiment and market performance.

26 Mar

3 Insider Monkey, 2:08 AM
Evolv Technologies Holdings, Inc. (EVLV) enters into a renewed and expanded agreement with the Houston Astros to deploy advanced security screening technology at stadium venues. Renewed and expanded partnership with Houston Astros strengthens EVLV's foothold in sports venues, potentially boosting revenue and market sentiment moderately.

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us